Related Experiment Video
Updated: Jul 11, 2026

Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
Engineered Streptococcus suis Bacterial Ghosts via Lytic Plasmid and Cell-Penetrating Peptides for Enhanced
Jianan Liu1,2, Xinming Pan1,2, Wanxia Pu1,2
1MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, China.
None:
Bacterial ghosts (BGs) prepared by biological methods effectively preserve their morphological and antigenic characteristics, making them excellent vaccine carriers for robust immune response. Streptococcus suis is a zoonotic pathogen that causes severe human infections such as meningitis and bacteremia, while also imposing significant economic losses in livestock, posing dual threats to public health and food safety. This study identified that CrfP, a murein hydrolase that induces BG production in S. suis (SSBGs), functions by forming pores during natural transformation. A shuttle plasmid pKSET CrfP is then constructed to achieve anhydrotetracycline-inducible SSBGs generation. The screened WR12, a cell-penetrating peptide (CPP), significantly enhanced the production of SSBGs and achieved a 100% inactivation for vaccine preparation. Immunization with SSBGs elicited a robust immune response, characterized by the production of IgG1 and IgG2a antibodies and the activation of CD4+ T lymphocytes, crucial for humoral immunity. The SSBGs vaccine exhibited excellent protective efficacy against S. suis challenge in a mouse model. These findings establish a scalable method for Gram-positive BG vaccines and introduce CrfP as a template for lytic enzyme discovery in other pathogens. The work advances a versatile platform for next-generation vaccines against emerging infections.
More Related Videos
13:53Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022